IL-1β and IL-18, generated upon NLRP3 inflammasome activation, emerge as critical pro-inflammatory mediators in innate immunity, exerting a pivotal influence on the initiation and advancement of RA [84]. The gene discussed is NLRP3; the disease is rheumatoid arthritis.